+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Autoimmune Disease"

From
From
Global Alopecia Treatment Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Global Alopecia Treatment Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 133 Pages
  • Global
From
From
From
From
Multiple Sclerosis Forecast and Market Analysis to 2025 - Product Thumbnail Image

Multiple Sclerosis Forecast and Market Analysis to 2025

  • Report
  • July 2018
  • 765 Pages
  • Global
From
Biosimilars in Immunology - Product Thumbnail Image

Biosimilars in Immunology

  • Report
  • February 2020
  • 137 Pages
  • Global
From
Disease Analysis: Ulcerative Colitis - Product Thumbnail Image

Disease Analysis: Ulcerative Colitis

  • Report
  • May 2021
  • 103 Pages
  • Global
Market Spotlight: Systemic Lupus Erythematosus (SLE) - Product Thumbnail Image

Market Spotlight: Systemic Lupus Erythematosus (SLE)

  • Report
  • May 2021
  • 40 Pages
  • Global
From
Crohn's Disease: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Crohn's Disease: Dynamic Market Forecast to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Loading Indicator

The Autoimmune Disease market within the context of Allergy and Immunology is a rapidly growing field of medical research and treatment. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment for autoimmune diseases typically involves immunosuppressive drugs, which reduce the activity of the immune system, and biologics, which target specific parts of the immune system. In recent years, the development of new treatments for autoimmune diseases has been a major focus of research and development in the Allergy and Immunology field. Companies in this market are focused on developing new treatments, such as monoclonal antibodies, small molecule drugs, and gene therapies. Examples of companies in this market include AbbVie, Amgen, Biogen, Celgene, Gilead, and Regeneron. Show Less Read more